Unveiling 7 Analyst Insights On Avidity Biosciences
Unveiling 7 Analyst Insights On Avidity Biosciences
揭示关于avidity biosciences的7个分析师见解
In examining recent analyst...Across the recent three months, 7 analysts have shared their insights on Avidity Biosciences (NASDAQ:RNA), expressing a variety of opinions spanning from bullish to bearish.
在最近的三个月里，有7位分析师就Avidity Biosciences (纳斯达克:RNA)发表了自己的见解，表达了从看好到看淡的不同观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $68.86, a high estimate of $96.00, and a low estimate of $53.00. Observing a 4.33% increase, the current average has risen from the previous average price target of $66.00.
The 12-month price targets, analyzed by analysts, offer insights with an average target of $68.86, a high estimate of $96.00, and a low estimate of $53.00. Observing a 4.33% increase, the current average has risen from the previous average price target of $66.00.
Exploring Analyst Ratings: An In-Depth Overview
分析师评级:深入了解
In examining recent analyst...
通过审视...
登录免费看全文
登录/注册
资讯热榜
更新时间